Acetic Acid → 5{(1R)-2-[(6-{4-[3-(Cyclopentylsulfonyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-hydroxyphenylformamide acetate
反応式
C([N:8]([CH2:29][CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][O:35][CH2:36][CH2:37][CH2:38][CH2:39][C:40]1[CH:45]=[CH:44][CH:43]=[C:42]([S:46]([CH:49]2[CH2:53][CH2:52][CH2:51][CH2:50]2)(=[O:48])=[O:47])[CH:41]=1)[CH2:9][C@@H:10]([C:12]1[CH:13]=[CH:14][C:15]([O:21]CC2C=CC=CC=2)=[C:16]([NH:18][CH:19]=[O:20])[CH:17]=1)[OH:11])C1C=CC=CC=1.[C:54]([OH:57])(=[O:56])[CH3:55]>CCO.[Pd].[OH-].[OH-].[Pd+2]>[C:54]([OH:57])(=[O:56])[CH3:55].[CH:49]1([S:46]([C:42]2[CH:41]=[C:40]([CH2:39][CH2:38][CH2:37][CH2:36][O:35][CH2:34][CH2:33][CH2:32][CH2:31][CH2:30][CH2:29][NH:8][CH2:9][C@@H:10]([C:12]3[CH:13]=[CH:14][C:15]([OH:21])=[C:16]([NH:18][CH:19]=[O:20])[CH:17]=3)[OH:11])[CH:45]=[CH:44][CH:43]=2)(=[O:48])=[O:47])[CH2:53][CH2:52][CH2:51][CH2:50]1参加物
6
反応物 2
生成物 1
試薬・触媒・溶媒 3
実験手順
5-{(1R)-2-[Benzyl(6-{4-[3-(cyclopentylsulfonyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(benzyloxy)phenylformamide (17 mg) was dissolved in EtOH (10 ml) and glacial acetic acid (1 ml) added. The solution was hydrogenated using 10% palladium on carbon (50% water by weight, 7 mg) and 20% palladium hydroxide on carbon (7 mg) for 20 h. The catalyst was removed by filtration and the filtrate was evaporated in vacuo. The residue was purified on an isolute aminopropyl cartridge (2 g), eluting with MeOH-DCM mixtures. Evaporation of the appropriate fractions with AcOH gave the title compound, (5 mg) LCMS RT=2.53 min, ES+ve 561 (MH)+
後処理
- customfor 20 h
- customThe catalyst was removed by filtration
- customthe filtrate was evaporated in vacuo
- customThe residue was purified on an isolute aminopropyl cartridge (2 g)
- washeluting with MeOH-DCM mixtures
- customEvaporation of the appropriate fractions with AcOH
出典と根拠
- ORDレコード
- ord-b06b66cad84944fe97bb40d75f2209cd
- 出典データセット
- uspto-grants-2008_10
- 特許番号
- US07442839B2
反応ノート
読み込み中…